U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday. The ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
Food additives have been a huge topic in the U.S. for years, but really caught fire earlier this month when the U.S. Food and ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
Last week, the Food and Drug Administration banned Red Dye No. 3 over cancer risks. Good.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...